DE
INSIDER · TVTX · Travere Therapeutics, Inc. · CHIEF EXECUTIVE OFFICER
Dube Eric M
Every open-market transaction filed under this name, Sep 15 to Sep 17.
Filings
8
0 buys · 8 sells
Bought
—
open market, at cost
Sold
$25.4M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Sep 17 | TVTX | Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sell | 6,802 | $64.95 | $442K | −3.8% |
| Sep 17 | TVTX | Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sell | 101,691 | $64.59 | $6.6M | −3.2% |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sell | 96,125 | $63.64 | $6.1M | −1.8% |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sell | 99,716 | $63.26 | $6.3M | −1.2% |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sell | 270 | $65.31 | $18K | −4.3% |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sell | 3,102 | $63.64 | $197K | −1.8% |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sell | 28,796 | $62.66 | $1.8M | −0.2% |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sell | 63,498 | $61.99 | $3.9M | +0.8% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.